Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Pharmacokinetics-Pharmacodynamics (PK-PD) Profile, Effectiveness and Safety of ATM-AVI in Special PopulationsRelease Date:Research Inflammation & Immunology China Impact of Rapid Diagnostic Tests (RDTs) on Treatment Pattern and Outcomes in Patients with Carbapenem-Resistant (CR) PathogensRelease Date:Research Inflammation & Immunology China Initiatives to Improve the Clinical Environment for Dermatologic Immunology, Inflammation, and Allergy CareRelease Date:Partner: The Japanese Society for Cutaneous Immunology and AllergyQuality Improvement Inflammation & Immunology Japan Real World, Long-term Efficacy Study of Ritlecitinib in Adult and Adolescent Patients with Severe Alopecia Areata in ChinaRelease Date:Research Inflammation & Immunology China Epidemiology and surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs) in the UKRelease Date:Research Internal Medicine United Kingdom Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC)Education Oncology All Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache DisordersQuality Improvement Internal Medicine Canada, USA Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease China Real-World Atopic Dermatitis: Italian Insights GrantRelease Date:Research Inflammation & Immunology Italy Title Grant Type Focus Area Country Application Due Date Cardiac Transthyretin Amyloid (ATTR) FellowshipRelease Date:Partner: International Society of AmyloidosisFellowship Rare Disease All Clinical Diagnosis and Management of EndometriosisEducation Internal Medicine USA Management of Uterine FibroidsEducation Internal Medicine USA Rapid Education on Drug-Drug Interactions in COVID-19 Outpatient TreatmentRelease Date:Education Hospital USA 2023 Global Migraine ASPIRERelease Date:Research Internal Medicine All Promoting Pain Treatment in Musculoskeletal PainRelease Date:Education Internal Medicine Japan Improve the Treatment Environment for Cancer Pain PatientsRelease Date:Education Internal Medicine Japan LMIC Pharmacovigilance EducationRelease Date:Education Patient Safety Kenya, Lesotho, Swaziland Knowledge Gaps in Managing Obesity and COVID-19Release Date:Education Hospital USA Immunotherapy in Urothelial Carcinoma (USA, Europe, Asia, Latin America, Canada, and Global)Release Date:Partner: Merck KGaA, Darmstadt, Germany, EMD SeronoEducation Oncology All Promoting timely diagnosis of ATTR-CM in China Competitive Grant Program - internal Pfizer review processRelease Date:Quality Improvement Rare Disease China Quality Improvement Initiatives to Address Healthcare Barriers for Cardiac AmyloidosisRelease Date:Partner: National Medical AssociationQuality Improvement Rare Disease USA